Advanced search
Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 42, 2020 - Issue 2
Submit an article Journal homepage
78
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH PAPER

New MRI lesions and topography at 6 months of treatment initiation and disease activity during follow up in relapsing remitting multiple sclerosis patients

Facundo SilveiraServicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, ArgentinaView further author information
,
Francisco SánchezCentro de Esclerosis Múltiple de Buenos Aires, Buenos Aires, ArgentinaView further author information
,
Jimena MiguezServicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina;Centro de Esclerosis Múltiple de Buenos Aires, Buenos Aires, ArgentinaView further author information
,
Laura ContarteseServicio d Neurología, Hospital de Clínicas José de San Martin, Buenos Aires, ArgentinaView further author information
,
Alejandra GómezServicio de Neurología, Hospital Ramos Mejía, Buenos Aires, ArgentinaView further author information
,
Liliana PatruccoServicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina;Centro de Esclerosis Múltiple de Buenos Aires, Buenos Aires, ArgentinaView further author information
,
Edgardo CristianoCentro de Esclerosis Múltiple de Buenos Aires, Buenos Aires, ArgentinaView further author information
&
Juan Ignacio RojasServicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina;Centro de Esclerosis Múltiple de Buenos Aires, Buenos Aires, ArgentinaCorrespondence[email protected]
View further author information
 show all
Pages 148-152 | Received 15 Jul 2019, Accepted 25 Dec 2019, Published online: 20 Jan 2020

References

  • Di Filippo M, Anderson VM, Altmann DR, et al. Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2011;81:204–208.
  • Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359:1221–1231.
  • Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med. 2000;343:938–952.
  • Thompson AJ, Baranzini SE, Geurts J, et al. Multiple sclerosis. Lancet. 2018;391:1622–1636.
  • Rio J. Comabella M and Montalban X. Predicting responders to therapies for multiple sclerosis. Nat Rev Neurol. 2009;5:553–560.
  • Sormani MP, Gasperini C, Romeo M, et al. Assessing response to interferon-beta in a multicenter dataset of patients with MS. Neurology. 2016;87:134–140.
  • Wattjes MP, Rovira A, Miller D, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis–establishing disease prognosis and monitoring patients. Nat Rev Neurol. 2015;11:597–606.
  • Rovira A, Wattjes MP, Tintore M, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol. 2015;11:471–482.
  • Rio J, Auger C, Rovira A. MR imaging in monitoring and predicting treatment response in multiple sclerosis. Neuroimaging Clin N Am. 2017;27:277–287.
  • Gasperini C, Prosperini L, Tintore M, et al. Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge. Neurology. 2019;92:180–192.
  • Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162–173.
  • Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58:840–846.
  • Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.
  • Miller D, Barkhof F, Montalban X, et al. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005;4:281–288.
  • Traboulsee A, Simon J, Stone L, et al. Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. Am J Neuroradiol. 2016;37:394–401.
  • Filippi M, Rocca MA, Ciccarelli O, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016;15:292–303.
  • Smith SM, De Stefano N, Jenkinson M, et al. Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr. 2001;25:466–475.
  • Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 2002;17:479–489.
  • Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging. 2001;20:45–57.
  • Schmidt P. Bayesian inference for structured additive regression models for large-scale problems with applications to medical imaging. 2017. Available from: http://nbn-resolving.de/urn:nbn:de:bvb:19-203731
  • Schmidt P, Gaser C, Arsic M, et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. Neuroimage. 2012;59:3774–3783.
  • Kohler C, Wahl H, Ziemssen T, et al. Exploring individual multiple sclerosis lesion volume change over time: development of an algorithm for the analyses of longitudinal quantitative MRI measures. Neuroimage Clin. 2019;21:101623.
  • Galassi S, Prosperini L, Logoteta A, et al. A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta. Mult Scler Relat Disord. 2016;8:99–106.
  • Freedman MS, Selchen D, Arnold DL, et al. Treatment optimization in MS: Canadian MS Working Group updated recommendations. Can J Neurol Sci. 2013;40:307–323.
  • Cristiano E, Alonso R, Alvez Pinheiro A, et al. Corrigendum to “Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients” [J. Neurol. Sci. 385C (2018) 217–224]. J Neurol Sci. 2018;387:231–232.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.